BR112015010823A2 - composto de 2-piridona - Google Patents
composto de 2-piridonaInfo
- Publication number
- BR112015010823A2 BR112015010823A2 BR112015010823A BR112015010823A BR112015010823A2 BR 112015010823 A2 BR112015010823 A2 BR 112015010823A2 BR 112015010823 A BR112015010823 A BR 112015010823A BR 112015010823 A BR112015010823 A BR 112015010823A BR 112015010823 A2 BR112015010823 A2 BR 112015010823A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pyridone compound
- pyridone
- tautomer
- solvate
- Prior art date
Links
- -1 2-pyridone compound Chemical class 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000003213 activating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
1/1 resumo composto de 2-piridona este composto de 2-piridona representado pela fórmula [1] ou um tautômero do dito composto, ou um sal farmaceuticamente aceitável do dito composto ou dito tautômero, ou um solvato do dito composto ou os semelhantes tem um efeito ativador de gk superior e é útil como um produto farmacêutico.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012249792 | 2012-11-13 | ||
| PCT/JP2013/080517 WO2014077235A1 (ja) | 2012-11-13 | 2013-11-12 | ２－ピリドン化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015010823A2 true BR112015010823A2 (pt) | 2017-07-11 |
Family
ID=50731146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015010823A BR112015010823A2 (pt) | 2012-11-13 | 2013-11-12 | composto de 2-piridona |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US9695148B2 (pt) |
| EP (1) | EP2921489B1 (pt) |
| JP (1) | JP5963025B2 (pt) |
| KR (1) | KR102160841B1 (pt) |
| CN (1) | CN104768944B (pt) |
| AU (1) | AU2013345930B2 (pt) |
| BR (1) | BR112015010823A2 (pt) |
| CA (1) | CA2891406C (pt) |
| DK (1) | DK2921489T3 (pt) |
| ES (1) | ES2641469T3 (pt) |
| HK (1) | HK1207856A1 (pt) |
| HU (1) | HUE034557T2 (pt) |
| IL (1) | IL238701B (pt) |
| IN (1) | IN2015DN03869A (pt) |
| MX (1) | MX361479B (pt) |
| MY (1) | MY173812A (pt) |
| NO (1) | NO2921489T3 (pt) |
| NZ (1) | NZ707832A (pt) |
| PH (1) | PH12015501056A1 (pt) |
| PL (1) | PL2921489T3 (pt) |
| PT (1) | PT2921489T (pt) |
| RU (1) | RU2662157C2 (pt) |
| SG (1) | SG11201503716RA (pt) |
| TW (1) | TWI591064B (pt) |
| WO (1) | WO2014077235A1 (pt) |
| ZA (1) | ZA201503323B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6048533B2 (ja) * | 2014-05-12 | 2016-12-21 | 日産化学工業株式会社 | ２−ピリドン化合物を含有する医薬 |
| KR20170003524A (ko) * | 2014-05-13 | 2017-01-09 | 닛산 가가쿠 고교 가부시키 가이샤 | 2-피리돈 화합물의 제조 방법 |
| US11963947B2 (en) * | 2018-05-31 | 2024-04-23 | Hua Medicine (Shanghai) Ltd. | Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and DPP-IV inhibitor, and preparation method and use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4275069A (en) | 1979-01-22 | 1981-06-23 | The Upjohn Company | Anti-diabetic 1,2-dihydro-2-oxo-6-alkyl-nicotinic acids |
| BR0009486B1 (pt) | 1999-03-29 | 2011-03-09 | composto que compreende uma amida, composição farmacêutica que compreende esse composto, seu uso e processo para a preparação do mesmo. | |
| US6353111B1 (en) | 1999-12-15 | 2002-03-05 | Hoffmann-La Roche Inc. | Trans olefinic glucokinase activators |
| BRPI0712862A2 (pt) | 2006-06-08 | 2012-12-18 | Lilly Co Eli | carboxamidas substituìdas |
| US8163779B2 (en) | 2006-12-20 | 2012-04-24 | Takeda San Diego, Inc. | Glucokinase activators |
| NZ582661A (en) * | 2007-07-17 | 2012-03-30 | Bristol Myers Squibb Co | Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| US20110130365A1 (en) | 2008-07-29 | 2011-06-02 | Benbow John W | Fluorinated Heteroaryls |
| AU2010327597B2 (en) * | 2009-12-04 | 2014-06-19 | Nissan Chemical Industries, Ltd. | 2-Pyridone compounds |
| JP2013010750A (ja) * | 2011-06-02 | 2013-01-17 | Taisho Pharmaceutical Co Ltd | ２−ピリドン化合物を含有する医薬 |
-
2013
- 2013-11-12 PL PL13855534T patent/PL2921489T3/pl unknown
- 2013-11-12 MY MYPI2015701491A patent/MY173812A/en unknown
- 2013-11-12 US US14/442,157 patent/US9695148B2/en active Active
- 2013-11-12 RU RU2015122717A patent/RU2662157C2/ru active
- 2013-11-12 KR KR1020157012117A patent/KR102160841B1/ko active IP Right Grant
- 2013-11-12 NO NO13855534A patent/NO2921489T3/no unknown
- 2013-11-12 JP JP2014546982A patent/JP5963025B2/ja not_active Expired - Fee Related
- 2013-11-12 MX MX2015005884A patent/MX361479B/es active IP Right Grant
- 2013-11-12 ES ES13855534.7T patent/ES2641469T3/es active Active
- 2013-11-12 IN IN3869DEN2015 patent/IN2015DN03869A/en unknown
- 2013-11-12 CA CA2891406A patent/CA2891406C/en not_active Expired - Fee Related
- 2013-11-12 WO PCT/JP2013/080517 patent/WO2014077235A1/ja active Application Filing
- 2013-11-12 SG SG11201503716RA patent/SG11201503716RA/en unknown
- 2013-11-12 BR BR112015010823A patent/BR112015010823A2/pt not_active Application Discontinuation
- 2013-11-12 DK DK13855534.7T patent/DK2921489T3/en active
- 2013-11-12 HU HUE13855534A patent/HUE034557T2/en unknown
- 2013-11-12 NZ NZ707832A patent/NZ707832A/en not_active IP Right Cessation
- 2013-11-12 CN CN201380059272.2A patent/CN104768944B/zh not_active Expired - Fee Related
- 2013-11-12 EP EP13855534.7A patent/EP2921489B1/en active Active
- 2013-11-12 PT PT138555347T patent/PT2921489T/pt unknown
- 2013-11-12 AU AU2013345930A patent/AU2013345930B2/en not_active Ceased
- 2013-11-13 TW TW102141288A patent/TWI591064B/zh not_active IP Right Cessation
-
2015
- 2015-05-07 IL IL238701A patent/IL238701B/en active IP Right Grant
- 2015-05-12 PH PH12015501056A patent/PH12015501056A1/en unknown
- 2015-05-13 ZA ZA2015/03323A patent/ZA201503323B/en unknown
- 2015-08-28 HK HK15108355.5A patent/HK1207856A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015018738A8 (pt) | compostos de tetra-hidropirrolotiazina, seus usos, e composição farmacêutica | |
| PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
| MX2015017861A (es) | Derivados de benzotiofeno como inhibidores del receptor de estrogeno. | |
| EA201690848A1 (ru) | Производные бициклического пиридила с конденсированными кольцами в качестве ингибиторов fgfr4 | |
| BR112015009850A2 (pt) | compostos de piridila substituídos por heteroarila úteis como moduladores de quinase | |
| PH12015501993B1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
| RS54873B1 (sr) | Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba | |
| IN2014MN02106A (pt) | ||
| BR112016011755A2 (pt) | derivado de ureia ou sal farmacologicamente aceitável do mesmo | |
| BR112016010080A8 (pt) | compostos de pirazolopirimidina, composição farmacêutica e seu uso | |
| MX2016001400A (es) | Derivados de piridazina 1,4-disustituida, y su uso para el tratamiento de afecciones relacionadas con la deficiencia de smn. | |
| EA201690247A1 (ru) | Аминометилбиарильные производные-ингибиторы фактора d комплемента и их применения | |
| BR112014026266A2 (pt) | derivado de quinazolidinadiona | |
| EA201692542A1 (ru) | Индановые и индолиновые производные и их применение в качестве активаторов растворимой гуанилатциклазы | |
| BR112015030399B8 (pt) | Derivados heterocíclicos, uso dos referidos derivados e composição farmacêutica para a prevenção ou tratamento de doenças associadas com a ativação da proteína stat3 | |
| EA201591815A1 (ru) | Бицикло [2.2.2] кислоты - модуляторы gpr120 | |
| BR112015024075A2 (pt) | compostos de piridinilpirazoloquinolina | |
| BR112015026967A8 (pt) | fenoxietil di-hidro-1h-isoquinolina, seus usos, e composição farmacêutica | |
| BR112015029348A2 (pt) | inibidores da bace | |
| BR112014026305A2 (pt) | derivado de quinazolidinadiona | |
| MX364400B (es) | Compuestos de tetraciclina. | |
| BR112012031340A2 (pt) | derivados de cianoquinolina | |
| EA201692298A1 (ru) | Производные карбоксамидов | |
| PH12015501386A1 (en) | Tricyclic compounds | |
| MX360699B (es) | Derivados de espiro [2.4] heptano puenteado substituidos por piperazina, utilizados como agonistas del receptor alx. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: NISSAN CHEMICAL INDUSTRIES, LTD. (JP) |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |